Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
EYLEA’s unique MoA: What is the rationale for the higher molar dose?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results